Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection (SOLID)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04407143|
Recruitment Status : Recruiting
First Posted : May 29, 2020
Last Update Posted : October 22, 2020
Observational, retrospective data collection and prospective IgG analysis, and multicenter study.
The main objective of the study is th description of the characteristics and evolution of patients with lung cancer who have acquired COVID-19 infection.
For the identification of patients who contract COVID-19 infection, the IgG+ blood test by ELISA method will be used.
|Condition or disease||Intervention/treatment|
|Lung Cancer COVID Corona Virus Infection||Diagnostic Test: IgG test|
|Study Type :||Observational|
|Estimated Enrollment :||128 participants|
|Official Title:||Study of Acquired Immunity in Patients With Lung Cancer and COVID-19 Infection|
|Actual Study Start Date :||April 15, 2020|
|Estimated Primary Completion Date :||December 15, 2020|
|Estimated Study Completion Date :||December 31, 2020|
Lung cancer patients infected by COVID-19
Diagnostic Test: IgG test
IgG+ blood test by ELISA method.
- Description of the characteristics of patients [ Time Frame: From the diagnosis of the COVID until the determination of the blood IgGs, up to 10 weeks ]Description of the characteristics and evolution of patients with lung cancer who have contracted COVID-19 infection.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04407143
|Contact: Eva Pereiraemail@example.com|
|Principal Investigator:||Mariano Provencio, MD||Hospital Puerta de Hierro de Majadahonda de Madrid|